AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

URINARY INCONTINENCE AND GERIATRIC SYNDROMES

Recruitingn/aAges 65 Years - anyAllMERT UYSAL
💬

In plain words

What the trial is, and whether it could suit you

The aim of this cross-sectional observational study is to examine the independent associations of urinary incontinence severity and post-void residual urine volume with frailty and other geriatric outcomes in older adults presenting to a urology outpatient clinic with urinary incontinence.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age 65 years or older, * Presence of involuntary urinary leakage according to the International Continence Society definition, * At least one urinary leakage episode during the previous four weeks and an ICIQ-UI SF score of ≥1, * General health status adequate to tolerate the outpatient assessment protocol, * Ability to mobilize independently, * Ability to understand instructions in Turkish and complete the study questionnaires, * Willingness to participate and provision of written informed consent. Exclusion Criteria: * Acute urinary tract infection or acute lower urinary tract symptoms, * History of major pelvic or orthopedic surgery within the previous six months, * Acute musculoskeletal condition that may affect performance during the assessments, * Neurological disease causing severe mobility limitations, including Parkinson's disease or stroke, * Diabetic neuropathy, * Severe cardiopulmonary disease, including New York Heart Association class III-IV heart failure or forced expiratory volume in one second below 30% of the predicted value, * Dementia or severe cognitive impairment, defined as Global Deterioration Scale stage 4 or higher, * Severe visual or hearing impairment that may prevent completion of the assessments, * Terminal illness or active malignancy, * Inability or unwillingness to provide informed consent, * Unwillingness or inability to complete the assessment protocol.
💊

What it tests

  • Not listed
📍

Where

1 site
Karabuk Training and Research Hospital
Karabük, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy